Home / Merck & CO INC. (MRK)
Sponsor pipeline · MRK

Merck & CO INC.

Forward clinical-stage catalysts linked to MRK

13
Tracked catalysts (sample)
10
Clinical-stage assets
2026-08-01
Nearest catalyst
tulisokibart
READOUT · Phase 32026-08-01
belzutifan
READOUT · Phase 32026-10-28
enlicitide decanoate
READOUT · Phase 32026-12-02
rosuvastatin calcium
READOUT · Phase 32026-12-02
ibrutinib
READOUT · Phase 32026-12-31
rescue medications
READOUT · Phase 32027-01-04
supportive care measures
READOUT · Phase 32027-01-04
ifinatamab deruxtecan
READOUT · Phase 32027-04-30
nemtabrutinib
READOUT · Phase 32027-05-19
tocilizumab
READOUT · Phase 32027-08-31
!

Data, not investment advice. CSA is information, not a recommendation to buy, sell or hold any security. Estimated catalyst dates routinely slip and are graded by confidence — verify against the source link before acting.

This sponsor's catalysts are a slice of the free CSA sample. The full snapshot spans 139 listed sponsors and 2,103 forward catalysts.

Get the full dataset — $499 →